Sumitomo Pharma Co., Ltd. (TYO:4506)

Sumitomo Pharma Revenue

Sumitomo Pharma had revenue of 129.50B JPY in the quarter ending June 30, 2026, with 19.90% growth. This brings the company's total for the last twelve months to 474.79B, up 14.09% year-over-year. In the fiscal year ending March 31, 2026, Sumitomo Pharma had annual revenue of 453.29B with 13.66% growth. That makes Sumitomo Pharma the 3,778th largest company in the world by revenue and 377th in Japan.

• Revenue (ttm): 474.79B
• Revenue Growth: +14.09%
• P/S Ratio: 1.75
• Revenue / Employee: 123.90M
• Employees: 4,980
• Market Cap: 831.47B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals - North America 337.92B 74.5%
• Pharmaceuticals - Japan 92.37B 20.4%
• Pharmaceuticals - Asia 23.01B 5.1%

By Geography

Chart

• United States of America 320.66B 70.7%
• Japan 84.77B 18.7%
• Others (Excl. China) 26.64B 5.9%
• China 19.34B 4.3%
• North America (Excl. United States) 1.88B 0.4%

Fiscal year ended Mar 31, 2026 See the full Sumitomo Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	453.29B	54.46B	13.66%
Mar 31, 2025	398.83B	84.27B	26.79%
Mar 31, 2024	314.56B	-240.99B	-43.38%
Mar 31, 2023	555.54B	-4.49B	-0.80%
Mar 31, 2022	560.04B	44.08B	8.54%

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error